Profile | GDS4284 / 213180_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1173.74 | 76 |
GSM687648 | Patient 402 control | 1531.54 | 80 |
GSM687653 | Patient 403 control | 1428.04 | 79 |
GSM687658 | Patient 404 control | 907.271 | 73 |
GSM687663 | Patient 411 control | 1504.75 | 80 |
GSM687668 | Patient 422 control | 1482.34 | 80 |
GSM687673 | Patient 424 control | 1098.66 | 75 |
GSM687678 | Patient 425 control | 1097.87 | 75 |
GSM687683 | Patient 427 control | 1121.86 | 75 |
GSM687688 | Patient 428 control | 1233.45 | 77 |
GSM687695 | Patient 441 control | 1153.74 | 77 |
GSM687699 | Patient 443 control | 1207.8 | 77 |
GSM687704 | Patient 444 control | 1505.63 | 80 |
GSM687707 | Patient 448 control | 1225.08 | 77 |
GSM687712 | Patient 449 control | 943.031 | 73 |
GSM687719 | Patient 450 control | 1363.74 | 79 |
GSM687724 | Patient 451 control | 1169.29 | 77 |
GSM687728 | Patient 452 control | 1331.26 | 79 |
GSM687646 | Patient 401 treated 24h | 1519.73 | 80 |
GSM687649 | Patient 402 treated 24h | 1358.96 | 78 |
GSM687665 | Patient 411 treated 24h | 1526.24 | 80 |
GSM687651 | Patient 402 treated 4 weeks | 1550.3 | 80 |
GSM687667 | Patient 411 treated 4 weeks | 1271.96 | 77 |
GSM687670 | Patient 422 treated 24h | 1650.06 | 81 |
GSM687671 | Patient 422 treated 4 weeks | 1798.71 | 82 |
GSM687654 | Patient 403 treated 24h | 1300.61 | 78 |
GSM687675 | Patient 424 treated 24h | 1149.98 | 76 |
GSM687685 | Patient 427 treated 24h | 1134.57 | 76 |
GSM687656 | Patient 403 treated 4 weeks | 1548.52 | 80 |
GSM687677 | Patient 424 treated 4 weeks | 1012.9 | 74 |
GSM687687 | Patient 427 treated 4 weeks | 1171.41 | 76 |
GSM687692 | Patient 428 treated 4h | 1269.03 | 77 |
GSM687716 | Patient 449 treated 4h | 1059.47 | 75 |
GSM687722 | Patient 450 treated 4h | 1147.82 | 76 |
GSM687680 | Patient 425 treated 24h | 1046.88 | 74 |
GSM687690 | Patient 428 treated 24h | 1107.84 | 76 |
GSM687700 | Patient 443 treated 24h | 1322.89 | 78 |
GSM687705 | Patient 444 treated 24h | 1239.11 | 77 |
GSM687714 | Patient 449 treated 24h | 809.911 | 71 |
GSM687721 | Patient 450 treated 24h | 1311.6 | 78 |
GSM687682 | Patient 425 treated 4 weeks | 847.795 | 72 |
GSM687694 | Patient 428 treated 4 weeks | 1245.05 | 77 |
GSM687702 | Patient 443 treated 4 weeks | 1274.54 | 77 |
GSM687718 | Patient 449 treated 4 weeks | 700.374 | 69 |
GSM687723 | Patient 450 treated 4 weeks | 1215.23 | 77 |
GSM687661 | Patient 404 treated 4h | 1301.74 | 78 |
GSM687710 | Patient 448 treated 4h | 1695.24 | 82 |
GSM687726 | Patient 451 treated 4h | 1444.53 | 80 |
GSM687730 | Patient 452 treated 4h | 1747.2 | 83 |
GSM687660 | Patient 404 treated 24h | 686.458 | 70 |
GSM687697 | Patient 441 treated 24h | 1025.13 | 75 |
GSM687709 | Patient 448 treated 24h | 1388.83 | 79 |
GSM687725 | Patient 451 treated 24h | 1399.38 | 79 |
GSM687729 | Patient 452 treated 24h | 1267.9 | 79 |
GSM687727 | Patient 451 treated 4 weeks | 1133.54 | 76 |
GSM687731 | Patient 452 treated 4 weeks | 1604.28 | 81 |